Scarica l'app Stockscreener
5.78
1.05%
0.06
Dopo l'orario di chiusura:
5.84
0.06
+1.04%
Precedente Chiudi:
$5.72
Aprire:
$5.76
Volume 24 ore:
466.26K
Relative Volume:
1.22
Capitalizzazione di mercato:
$223.00M
Reddito:
-
Utile/perdita netta:
$-42.05M
Rapporto P/E:
-2.0496
EPS:
-2.82
Flusso di cassa netto:
$-35.26M
1 W Prestazione:
+3.03%
1M Prestazione:
+88.27%
6M Prestazione:
+44.50%
1 anno Prestazione:
+210.75%
Intervallo 1D:
$5.55
$5.92
Intervallo di 1 settimana:
$5.15
$5.92
Portata 52W:
$1.77
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Nome
Protara Therapeutics Inc
Settore
Industria
Telefono
646-844-0337
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK, NY
Confronta TARA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
5.78 | 206.80M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-16 | Iniziato | Scotiabank | Sector Outperform |
| 2025-03-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Ripresa | Guggenheim | Buy |
| 2021-06-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-02-17 | Iniziato | Oppenheimer | Outperform |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-07-29 | Iniziato | Guggenheim | Buy |
Mostra tutto
Protara Therapeutics Inc Borsa (TARA) Ultime notizie
Building trade automation scripts for Protara Therapeutics Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Measuring Protara Therapeutics Inc.’s beta against major indicesJuly 2025 Review & Low Risk High Win Rate Stock Picks - newser.com
Will Protara Therapeutics Inc. price bounce be sustainable2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reportsTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
Will Protara Therapeutics Inc. stock attract more institutional investorsJuly 2025 Big Picture & Accurate Intraday Trading Signals - newser.com
Trend analysis for Protara Therapeutics Inc. this weekEarnings Recap Report & Daily Oversold Stock Bounce Ideas - newser.com
Is Protara Therapeutics Inc. stock a safe haven assetPortfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
How to forecast Protara Therapeutics Inc. trends using time series2025 Market Sentiment & Short-Term High Return Ideas - newser.com
Custom watchlist performance reports with Protara Therapeutics Inc.July 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Statistical indicators supporting Protara Therapeutics Inc.’s strength2025 Technical Patterns & Weekly Momentum Picks - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policiesQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
How institutional ownership impacts Protara Therapeutics Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Exit strategy if you’re trapped in Protara Therapeutics Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
Will Protara Therapeutics Inc. bounce back from current supportJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Can a trend reversal in Protara Therapeutics Inc. lead to recoveryMarket Activity Summary & Real-Time Sentiment Analysis - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 2025Quarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Why hedge funds are buying Protara Therapeutics Inc. stockShare Buyback & Verified Momentum Stock Watchlist - newser.com
Protara Therapeutics' (TARA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Key resistance and support levels for Protara Therapeutics Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
Advanced analytics toolkit walkthrough for Protara Therapeutics Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Is Protara Therapeutics Inc. stock a contrarian buyProfit Target & Trade Opportunity Analysis - newser.com
Is Protara Therapeutics Inc. showing signs of accumulationWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Will Protara Therapeutics Inc. stock sustain high P E ratiosSwing Trade & Long-Term Safe Investment Ideas - newser.com
Will Protara Therapeutics Inc. (1KPA) stock see valuation expansion2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
Protara Therapeutics Inc Azioni (TARA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Protara Therapeutics Inc Azioni (TARA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zummo Jacqueline | Chf Scientific Operations Off |
Mar 26 '25 |
Sale |
4.53 |
21,224 |
96,145 |
98,861 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):